{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:03:46Z","timestamp":1789243426787,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81470863"],"award-info":[{"award-number":["No. 81470863"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 81670547"],"award-info":[{"award-number":["No. 81670547"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Key Research and Development Program of China","award":["No. 2017YFC0908100"],"award-info":[{"award-number":["No. 2017YFC0908100"]}]},{"name":"the National Key Research and Development Program of China","award":["No. 2017YFC0908104"],"award-info":[{"award-number":["No. 2017YFC0908104"]}]},{"name":"the Beijing Municipal Administration of Hospitals","award":["XMLX201711 to JC"],"award-info":[{"award-number":["XMLX201711 to JC"]}]},{"name":"the Beijing Municipal Administration of Hospitals\u2019 Ascent Plan","award":["DFL20151701"],"award-info":[{"award-number":["DFL20151701"]}]},{"name":"the National Science and Technology Major Project","award":["2017ZX10201201-002-004"],"award-info":[{"award-number":["2017ZX10201201-002-004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12072-019-09997-6","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T14:02:55Z","timestamp":1574431375000},"page":"145-160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["TAF and TDF attenuate liver fibrosis through NS5ATP9, TGF\u03b21\/Smad3, and NF-\u03baB\/NLRP3 inflammasome signaling pathways"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7937-8097","authenticated-orcid":false,"given":"Jing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"issue":"1","key":"9997_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4254\/wjh.v10.i1.1","volume":"10","author":"JA Del Campo","year":"2018","unstructured":"Del Campo JA, Gallego P, Grande L. Role of inflammatory response in liver diseases: therapeutic strategies. World J Hepatol 2018;10(1):1\u20137.","journal-title":"World J Hepatol"},{"key":"9997_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.matbio.2017.12.012","volume":"68\u201369","author":"E Roeb","year":"2018","unstructured":"Roeb E. Matrix metalloproteinases and liver fibrosis (translational aspects). Matrix Biol 2018;68\u201369:463\u2013473.","journal-title":"Matrix Biol"},{"issue":"2","key":"9997_CR3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. Electronic address EEE, European Association for the Study of the L. EASL Clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol 2018;69(2):406\u2013460.","journal-title":"J Hepatol"},{"issue":"1","key":"9997_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.abb.2008.08.005","volume":"479","author":"K Li","year":"2008","unstructured":"Li K, Ma Q, Shi L, Dang C, Hong Y, Wang Q, et al. NS5ATP9 gene regulated by NF-kappaB signal pathway. Arch Biochem Biophys 2008;479(1):15\u201319.","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"9997_CR5","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1159\/000489365","volume":"46","author":"DM Wu","year":"2018","unstructured":"Wu DM, Han XR, Wen X, Wang S, Fan SH, Zhuang J, et al. Salidroside protection against oxidative stress injury through the Wnt\/beta-catenin signaling pathway in rats with Parkinson\u2019s disease. Cell Physiol Biochem 2018;46(5):1793\u20131806.","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"9997_CR6","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.bbagen.2018.01.018","volume":"1862","author":"P Marchetti","year":"2018","unstructured":"Marchetti P, Trinh A, Khamari R, Kluza J. Melanoma metabolism contributes to the cellular responses to MAPK\/ERK pathway inhibitors. Biochim Biophys Acta 2018;1862(4):999\u20131005.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"9997_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.canlet.2007.10.029","volume":"259","author":"L Shi","year":"2008","unstructured":"Shi L, Zhang SL, Li K, Hong Y, Wang Q, Li Y, et al. NS5ATP9, a gene up-regulated by HCV NS5A protein. Cancer Lett 2008;259(2):192\u2013197.","journal-title":"Cancer Lett"},{"issue":"24","key":"9997_CR8","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.1016\/j.jmb.2017.10.014","volume":"429","author":"E Karg","year":"2017","unstructured":"Karg E, Smets M, Ryan J, Forne I, Qin W, Mulholland CB, et al. Ubiquitome analysis reveals PCNA-associated factor 15 (PAF15) as a specific ubiquitination target of UHRF1 in embryonic stem cells. J Mol Biol 2017;429(24):3814\u20133824.","journal-title":"J Mol Biol"},{"issue":"4","key":"9997_CR9","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1167\/iovs.15-18665","volume":"57","author":"G Li","year":"2016","unstructured":"Li G, Luna C, Gonzalez P. miR-183 inhibits UV-induced DNA damage repair in human trabecular meshwork cells by targeting of KIAA0101. Invest Ophthalmol 2016;57(4):2178\u20132186.","journal-title":"Invest Ophthalmol"},{"issue":"6","key":"9997_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/jvh.12155","volume":"21","author":"M Quan","year":"2014","unstructured":"Quan M, Liu S, Li G, Wang Q, Zhang J, Zhang M, et al. A functional role for NS5ATP9 in the induction of HCV NS5A-mediated autophagy. J Viral Hepat 2014;21(6):405\u2013415.","journal-title":"J Viral Hepat"},{"issue":"1\u20132","key":"9997_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11010-013-1827-z","volume":"385","author":"Y Sang","year":"2014","unstructured":"Sang Y, Zang W, Yan Y, Liu Y, Fu Q, Wang K, et al. Study of differential effects of TGF-beta3\/BMP2 on chondrogenesis in MSC cells by gene microarray data analysis. Mol Cell Biochem 2014;385(1\u20132):191\u2013198.","journal-title":"Mol Cell Biochem"},{"key":"9997_CR12","doi-asserted-by":"publisher","first-page":"10633","DOI":"10.1038\/ncomms10633","volume":"7","author":"X Wang","year":"2016","unstructured":"Wang X, Jung YS, Jun S, Lee S, Wang W, Schneider A, et al. PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness. Nat Commun 2016;7:10633.","journal-title":"Nat Commun"},{"issue":"1","key":"9997_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s10753-014-0031-y","volume":"38","author":"M Zhang","year":"2015","unstructured":"Zhang M, Zhang J, Liu S, Wang Q, Lin G, Qiu R, et al. NS5ATP9 suppresses activation of human hepatic stellate cells, possibly via inhibition of Smad3\/phosphorylated-Smad3 expression. Inflammation 2015;38(1):278\u2013289.","journal-title":"Inflammation"},{"key":"9997_CR14","doi-asserted-by":"publisher","DOI":"10.7554\/elife.04525","author":"F Hladik","year":"2015","unstructured":"Hladik F, Burgener A, Ballweber L, Gottardo R, Vojtech L, Fourati S, et al. Mucosal effects of tenofovir 1% gel. eLife 2015. https:\/\/doi.org\/10.7554\/elife.04525.","journal-title":"eLife."},{"key":"9997_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/apt.15053","volume":"49","author":"MT Kuo","year":"2019","unstructured":"Kuo MT, Hu TH, Hung CH, Wang JH, Lu SN, Tsai KL, et al. Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir. Aliment Pharmacol Ther 2019;49:218\u2013228.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"9997_CR16","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jhep.2017.11.039","volume":"68","author":"K Agarwal","year":"2018","unstructured":"Agarwal K, Brunetto M, Seto WK, Lim YS, Fung S, Marcellin P, et al. 96\u00a0weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection. J Hepatol 2018;68(4):672\u2013681.","journal-title":"J Hepatol"},{"issue":"5","key":"9997_CR17","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/hep.29320","volume":"66","author":"GV Papatheodoridis","year":"2017","unstructured":"Papatheodoridis GV, Idilman R, Dalekos GN, Buti M, Chi H, van Boemmel F, et al. The risk of hepatocellular carcinoma decreases after the first 5\u00a0years of entecavir or tenofovir in Caucasians with chronic hepatitis B. Hepatology 2017;66(5):1444\u20131453.","journal-title":"Hepatology"},{"issue":"3","key":"9997_CR18","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hep.23785","volume":"52","author":"TT Chang","year":"2010","unstructured":"Chang TT, Liaw YF, Wu SS, Schiff E, Han KH, Lai CL, et al. Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 2010;52(3):886\u2013893.","journal-title":"Hepatology"},{"issue":"1","key":"9997_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamaoncol.2018.4070","volume":"5","author":"J Choi","year":"2019","unstructured":"Choi J, Kim HJ, Lee J, Cho S, Ko MJ, Lim YS. Risk of hepatocellular carcinoma in patients treated with entecavir vs. tenofovir for chronic hepatitis B: a Korean Nationwide Cohort Study. JAMA Oncol 2019;5(1):30\u201336.","journal-title":"JAMA Oncol"},{"issue":"4","key":"9997_CR20","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/hep.29275","volume":"66","author":"JM Bangen","year":"2017","unstructured":"Bangen JM, Hammerich L, Sonntag R, Baues M, Haas U, Lambertz D, et al. Targeting CCl4-induced liver fibrosis by RNA interference-mediated inhibition of cyclin E1 in mice. Hepatology 2017;66(4):1242\u20131257.","journal-title":"Hepatology"},{"key":"9997_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ejphar.2018.01.027","volume":"822","author":"YW Sun","year":"2018","unstructured":"Sun YW, Zhang YY, Ke XJ, Wu XJ, Chen ZF, Chi P, et al. Pirfenidone prevents radiation-induced intestinal fibrosis in rats by inhibiting fibroblast proliferation and differentiation and suppressing the TGF-beta1\/Smad\/CTGF signaling pathway. Eur J Pharmacol 2018;822:199\u2013206.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"9997_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jhep.2014.07.035","volume":"62","author":"L Chen","year":"2015","unstructured":"Chen L, Li J, Zhang J, Dai C, Liu X, Wang J, et al. S100A4 promotes liver fibrosis via activation of hepatic stellate cells. J Hepatol 2015;62(1):156\u2013164.","journal-title":"J Hepatol"},{"issue":"6","key":"9997_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/cancers10060183","volume":"10","author":"K Yoshida","year":"2018","unstructured":"Yoshida K, Matsuzaki K, Murata M, Yamaguchi T, Suwa K, Okazaki K. Clinico-pathological importance of TGF-beta\/Phospho-Smad signaling during human hepatic fibrocarcinogenesis. Cancers 2018;10(6):183.","journal-title":"Cancers"},{"key":"9997_CR24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fphar.2018.00455","volume":"9","author":"J Peng","year":"2018","unstructured":"Peng J. The pharmacological targets and clinical evidence of natural products with anti-hepatic inflammatory properties. Front Pharmacol 2018;9:455.","journal-title":"Front Pharmacol"},{"issue":"4","key":"9997_CR25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jhep.2016.12.018","volume":"66","author":"X Yu","year":"2017","unstructured":"Yu X, Lan P, Hou X, Han Q, Lu N, Li T, et al. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1beta production via suppressing the NF-kappaB pathway and ROS production. J Hepatol 2017;66(4):693\u2013702.","journal-title":"J Hepatol"},{"key":"9997_CR26","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.chemosphere.2018.06.171","volume":"209","author":"F Xu","year":"2018","unstructured":"Xu F, Ji Q, Zhang J, Huang W, Cao Z, Li Y. AlCl3 inhibits LPS-induced NLRP3 inflammasome activation and IL-1beta production through suppressing NF-kappaB signaling pathway in murine peritoneal macrophages. Chemosphere 2018;209:972\u2013980.","journal-title":"Chemosphere"},{"issue":"3","key":"9997_CR27","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/hep.26592","volume":"59","author":"A Wree","year":"2014","unstructured":"Wree A, Eguchi A, McGeough MD, Pena CA, Johnson CD, Canbay A, et al. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology 2014;59(3):898\u2013910.","journal-title":"Hepatology"},{"key":"9997_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mam.2018.06.003","volume":"65","author":"R Weiskirchen","year":"2019","unstructured":"Weiskirchen R, Weiskirchen S, Tacke F. Organ and tissue fibrosis: molecular signals, cellular mechanisms and translational implications. Mol Aspects Med 2019;65:2\u201315.","journal-title":"Mol Aspects Med"},{"issue":"1","key":"9997_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00011-014-0772-y","volume":"64","author":"X Li","year":"2015","unstructured":"Li X, Wang Y, Wang H, Huang C, Huang Y, Li J. Endoplasmic reticulum stress is the crossroads of autophagy, inflammation, and apoptosis signaling pathways and participates in liver fibrosis. Inflamm Res 2015;64(1):1\u20137.","journal-title":"Inflamm Res"},{"issue":"1","key":"9997_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12931-019-1102-2","volume":"20","author":"L Li","year":"2019","unstructured":"Li L, Zhao J, Zhou L, Chen J, Ma Y, Yu Y, et al. Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-beta1\/Smad3 signaling pathway. Respir Res 2019;20(1):163.","journal-title":"Respir Res"},{"issue":"4","key":"9997_CR31","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2017.05.022","volume":"67","author":"PF Ma","year":"2017","unstructured":"Ma PF, Gao CC, Yi J, Zhao JL, Liang SQ, Zhao Y, et al. Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice. J Hepatol 2017;67(4):770\u2013779.","journal-title":"J Hepatol"},{"issue":"6","key":"9997_CR32","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1002\/hep.26318","volume":"57","author":"A Chen","year":"2013","unstructured":"Chen A, Tang Y, Davis V, Hsu FF, Kennedy SM, Song H, et al. Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease. Hepatology 2013;57(6):2202\u20132212.","journal-title":"Hepatology"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-019-09997-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-019-09997-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-019-09997-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T01:15:28Z","timestamp":1605921328000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-019-09997-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["9997"],"URL":"https:\/\/doi.org\/10.1007\/s12072-019-09997-6","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"assertion":[{"value":"30 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Jing Zhao, Ming Han, Li Zhou, Pu Liang, Yun Wang, Shenghu Feng, Hongping Lu, Xiaoxue Yuan, Kai Han, Xiaofan Chen, Shunai Liu, and Jun Cheng declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"a) Statement of human rights: this chapter does not contain any studies with human participants performed by any of the authors. b) Statement on welfare of animals: all procedures performed in studies involving animals were in accordance with the ethical standards of Institute Research Ethics Committee of Beijing Ditan Hospital. The entire study was approved by the Institute Research Ethics Committee of Beijing Ditan Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}}]}}